MRC1 and Lynch syndrome: Deficiencies in the MMR system causing hypermutability or microsatellite instability (MSI) are usually assessed when screening for Lynch Syndrome (LS), either via PCR (polymerase chain reaction) or by determining MMR proteins through immunohistochemistry (IHC) analysis provided after resection/biopsy from different tumors [2,4,5,6].